Researcher
Lore Decoster
- Keywords:Medicine
- Disciplines:Cancer diagnosis, Cancer therapy
Affiliations
- Medical Oncology (Department)
Member
From1 Jun 2010 → Today - Laboratory for Medical and Molecular Oncology (Research group)
Member
From1 Jan 2010 → Today - Clinical sciences (Department)
Member
From1 Oct 2020 → Today - Clinical sciences (Department)
Member
From1 Oct 2020 → 20 Oct 2022 - Clinical sciences (Department)
Member
From1 Oct 2019 → 30 Sep 2022 - Clinical sciences (Department)
Member
From1 Oct 2019 → 30 Sep 2022 - Faculty of Medicine and Pharmacy (Faculty)
Member
From8 Dec 2016 → 5 Sep 2019 - Clinical sciences (Department)
Member
From1 May 2012 → 30 Apr 2018
Projects
1 - 1 of 1
- Interdisciplinary Network in Fundamental and Medical Research on Lung and Pancreatic Cancer [NITROGEN]From1 Jul 2021 → TodayFunding: BOF - projects
Publications
11 - 20 of 57
- A prospective, multicenter, noninterventional study of decision factors in the first-line treatment of metastatic non-small cell lung cancer(2022)
Authors: Anne Sibille, Frederique Bustin, Luciano Carestia, Gaetan Catala, Christophe Compère, Kristof Cuppens, Benoit Colinet, Stephanie Coulon, Nele De Brucker, Lore Decoster, et al.
Pages: 773-776 - Efficacy of a Flat Low Dose of Nivolumab in Advanced Cancer(2022)
Authors: Sofie Joris, Christel Fontaine, Lore Decoster, Jacques Vanderauwera, Kris Thielemans, Wim Waelput, Jacques De Grève
Pages: 1433-1437 - Transcutaneous Vagal Nerve Stimulation Alone or in Combination With Radiotherapy Stimulates Lung Tumor Infiltrating Lymphocytes But Fails to Suppress Tumor Growth(2021)
Authors: Eva Reijmen, Sven de Mey, Helena Van Damme, Kirsten De Ridder, Thierry Gevaert, Emmy De Blay, Luc Bouwens, Christine Collen, Lore Decoster, Marijke De Couck, et al.
- The Value of 18F-FDG PET/CT in Predicting the Response to PD-1 Blocking Immunotherapy in Advanced NSCLC Patients with High-Level PD-L1 Expression(2021)
Authors: Karolien Vekens, Hendrik Everaert, Bart Neyns, Bart Ilsen, Lore Decoster
Pages: 432-440 - Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium(2021)
Authors: Kristof Cuppens, Liesbet Lodewyckx, Ingel K. Demedts, Lore Decoster, Benoît Colinet, Koen Deschepper, Annelies Janssens, Daniella Galdermans, Thierry Pieters
Pages: 141-152 - Unplanned hospitalizations in older patients with cancer(2021)
Authors: Elke Hilde Lodewijckx, Cindy Kenis, Johan Flamaing, Philip DeBruyne, Inge De Groof, Christian Focan, Frank Cornélis, Vincent Verschaeve, Christian Bachmann, Dominique Bron, et al.
Pages: 368-374 - Methods for frailty screening and geriatric assessment in older adults with cancer(2021)
Authors: Martine Puts, Wee Kheng Soo, Ewa Szumacher, Lore Decoster
Pages: 16-22 - Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer(2020)
Authors: Yi-Long Wu, Masahiro Tsuboi, Jie He, Thomas John, Christian Grohe, Margarita Majem, Jonathan W Goldman, Konstantin Laktionov, Sang-We Kim, Terufumi Kato, et al.
Pages: 1711-1723 - The prognostic value of patient-reported Health-Related Quality of Life and Geriatric Assessment in predicting early death in 6769 older (≥70 years) patients with different cancer tumors(2020)
Authors: Chantal Quinten, Cindy Kenis, Lore Decoster, Philip R Debruyne, Inge De Groof, Christian Focan, Frank Cornelis, Vincent Verschaeve, Christian Bachmann, Dominique Bron, et al.
Pages: 926-936 - Real life safety and effectiveness of nivolumab in older patients with non-small cell lung cancer: Results from the Belgian compassionate use program(2020)
Authors: Sofie Joris, Thierry Pieters, Anne Sibille, Frederique Bustin, Laurence Jacqmin, HR Kalantari, VEERLE SURMONT, Jean-Charles Goeminne, frederic Clinckart, Karin Pat, et al.
Pages: 796-801